Cargando…
Pharmacotherapy of high-risk population for developing psychosis
ABSTRACT: Early interventions in high-risk population for psychotic disorder target both conversion rates and functional impairments. Existing guidelines (European Psychiatric Association, NICE, Canadian) do not consider drug treatment as the first-line choice, pharmaceuticals mostly complement leas...
Autor principal: | Mohr, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392984/ http://dx.doi.org/10.1192/j.eurpsy.2023.113 |
Ejemplares similares
-
Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021) -
Clinical high-risk criteria of psychosis in 8-
to 17-year-old community subjects and inpatients not suspected to develop psychosis: not pluripotential or transdiagnostic
por: Schultze-Lutter, F., et al.
Publicado: (2022) -
Neurocognitive Functioning of Adolescents with Clinical High Risk for Psychosis, other Psychiatric Symptoms, and Psychosis
por: Orlandi, M., et al.
Publicado: (2022) -
Predictors of functioning at clinical high-risk for psychosis
por: Omelchenko, M.
Publicado: (2022) -
Transition to Psychosis in Individuals at Clinical High Risk: Meta-analysis
por: Salazar De Pablo, G., et al.
Publicado: (2023)